Brodsky & Smith, LLC Announces Class Action Lawsuit Against Chindex International, Inc
Feb 21 14
Law office of Brodsky & Smith, LLC announced that it has commenced in Circuit Court for Montgomery County Maryland a class action lawsuit against the Board of Directors of Chindex International Inc. relating to the proposed acquisition by a buyer consortium including the company CEO. Under the terms of the transaction, Chindex shareholders will receive only $19.50 in cash for each share of Chindex stock they own. The lawsuit concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Chindex for not acting in the company's shareholders best interests in connection with the sale process. The lawsuit challenges the process used by the Chindex Board of Directors and alleges the Consortium is underpaying for Chindex.
Chindex International Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 09:30 AM
Dec 31 13
Chindex International Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 09:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Roberta Lipson, Co-Founder, Chief Executive Officer, President and Director.
Chindex International Inc. Presents at Oppenheimer 24th Annual Healthcare Conference, Dec-10-2013 02:45 PM
Dec 3 13
Chindex International Inc. Presents at Oppenheimer 24th Annual Healthcare Conference, Dec-10-2013 02:45 PM. Venue: The Crowne Plaza Hotel, New York, New York, United States.
Chindex International Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013; Provides Earnings Guidance for the Full Year 2013
Nov 11 13
Chindex International Inc. announced unaudited earnings results for the third quarter and nine months ended September 30, 2013. For the quarter, the company reported healthcare services revenue of $43,058,000 against $37,299,000 a year ago. Loss from operations was $2,774,000 against income from operations of $1,531,000 a year ago. Loss before income tax was $2,790,000 against income from operations of $814,000 a year ago. Net loss was $3,825,000 or $0.23 diluted per share against net loss of $664,000 or $0.04 diluted per share a year ago. Adjusted EBITDA was $4,980,000 against $6,044,000 a year ago. Adjusted EBITDA was down slightly from the prior year, largely due to lower-than-expected operating income and development expenses.
For the nine months, the company reported healthcare services revenue of $130,600,000 against $108,928,000 a year ago. Income from operations was $1,705,000 against $5,523,000 a year ago. Income before income tax was $600,000 against $5,076,000 a year ago. Net loss was $4,009,000 or $0.24 diluted per share against net income of $615,000 or $0.05 diluted per share a year ago. Purchases of property and equipment were $10,896,000 against $21,986,000 a year ago. Adjusted EBITDA was $19,665,000 against $19,248,000 a year ago. Net cash provided by operating activities was $809,000 against $9,481,000 a year ago.
The company now expects full year 2013, revenue growth to be in the high teens to low-twenties range and adjusted EBITDA growth to be between 5% to 10% over last year to between $29 million - $31 million. Again, these results largely from the lower-than-projected top line overall and start-up expense in the rehab project due to the delayed opening of the facility. Upcoming capital expenditure plan totals up to $46 million, consisting of up to $31 million for new hospital development programs, up to $8 million for existing facility maintenance and organic development and up to $6 million for investment in IT infrastructure to support more efficient communications among the growing staff. The company expects to deliver year-over-year revenue growth at a rate in the high teens to low 20s, with annual revenues of approximately $180 million to $183 million.
Chindex International Inc. to Report Q3, 2013 Results on Nov 11, 2013
Oct 31 13
Chindex International Inc. announced that they will report Q3, 2013 results at 9:00 AM, Eastern Standard Time on Nov 11, 2013